Estradiol Gel
Product Images NDC 72603-244

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 72603-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.25g Pouch (Estradiol Gel 0.1 0.25mg 0.25g)

Label for Estradiol Gel, 0.1%, containing 0.25 grams delivering 0.25 milligrams of estradiol. The label notes manufacturing by Novitium Pharma LLC and labeling by Northstar Rx LLC. It includes a lot number, expiration date placeholder, and barcode with the NDC 72603-241-01.*

FDA Label Image

0.25g Carton (Estradiol Gel 0.1 0.25mg 0.25g Carton)

Packaging label for Estradiol Gel 0.1%, 0.25 mg topical gel. The label states that each 0.25 g gel packet provides 0.25 mg estradiol, with 30 packets per box. The product is labeled for Rx only and includes storage instructions, manufacturer details (NorthStar Rx LLC, Memphis, TN and Novitium Pharma LLC, East Windsor, NJ), and a barcode. The label features blue and pink color blocks with the NorthStar logo.*

FDA Label Image

0.5g Pouch (Estradiol Gel 0.1 0.5mg 0.5g)

Label for Estradiol Gel 0.1%, topical gel providing 0.5 mg of estradiol per 0.5 g. Manufactured for NorthStar Rx LLC by Novitium Pharma LLC. Includes NDC 72603-242-01, lot number, expiration date placeholder, issue date 12/2023, and barcode.*

FDA Label Image

0.5g Carton (Estradiol Gel 0.1 0.5mg 0.5g Carton)

Packaging label for Estradiol Gel 0.1% topical gel, containing 0.5 mg estradiol per 0.5 g gel. The box includes 30 packets. Manufactured for NorthStar Rx LLC and by Novitium Pharma LLC, with storage instructions and a warning that the package is not child-resistant. NDC 72603-242-30 is visible on the label.*

FDA Label Image

0.75g Pouch (Estradiol Gel 0.1 0.75mg 0.75g)

Label for Estradiol Gel 0.1% topical gel, 0.75 g providing 0.75 mg estradiol. Manufactured for NorthStar Rx LLC and by Novitium Pharma LLC. Includes NDC 72603-243-01, lot number, expiration date placeholder, issue date 12/2023, and a barcode.*

FDA Label Image

0.75g Carton (Estradiol Gel 0.1 0.75mg 0.75g Carton)

Box label for Estradiol Gel, 0.1%, 0.75 mg strength. The label states that each packet contains 0.75 g of gel providing 0.75 mg estradiol. The package contains 30 packets. The product is topical gel labeled Rx only and is manufactured for NorthStar Rx LLC by Novitium Pharma LLC. The label includes storage instructions, warnings, and a barcode.*

FDA Label Image

1.25g Pouch (Estradiol Gel 0.1 1.25mg 1.25g)

Label for Estradiol Gel 0.1%, featuring NDC 72603-245-01. It shows the active strength as 1.25 grams gel providing 1.25 mg of estradiol. The label lists NorthStar Rx LLC as the labeler and Novitium Pharma LLC as the manufacturer. Lot number and expiration date placeholders are present, along with a barcode.*

FDA Label Image

1.25g Carton (Estradiol Gel 0.1 1.25mg 1.25g Carton)

Packaging label for Estradiol Gel 0.1%, 1.25 mg strength in 1.25 g gel packets. The label indicates that each packet provides 1.25 mg of estradiol. The package contains 30 packets. Manufactured or labeled by NorthStar Rx LLC, Memphis, TN. The label includes directions for topical use, storage instructions, and a barcode with the NDC 72603-245-30.*

FDA Label Image

1g Pouch (Estradiol Gel 0.1 1mg 1g)

Label for Estradiol Gel 0.1%, topical gel providing 1 mg of estradiol per gram. The label shows the NDC 72603-244-01, manufacturer details including Northstar Rx LLC as the labeler, and Novitium Pharma LLC as the manufacturer. It includes a lot number and barcode information.*

FDA Label Image

1g Carton (Estradiol Gel 0.1 1mg 1g Carton)

Packaging label for Estradiol Gel 0.1%, 1 mg topical gel. The label states one gram of gel provides 1 mg estradiol per packet. The box contains 30 packets and is labeled for prescription use only. The product is manufactured for NorthStar Rx LLC and includes storage instructions and a barcode.*

FDA Label Image

Figure-a (Figure A)

An instructional illustration showing two hands peeling back the corner of a protective seal or cover, likely demonstrating how to open a sealed package or pharmaceutical container for the topical gel product Estradiol.*

FDA Label Image

Figure-b (Figure B)

An illustration showing a person seated with hands applying gel onto the inner thigh, demonstrating the topical application of the medication Estradiol gel.*

FDA Label Image

Figure-c (Figure C)

An instructional illustration showing a person applying topical gel to the inner thigh area, suggesting a site for application.*

FDA Label Image

Figure-one (Figure One)

A line graph showing mean serum estradiol concentration (pg/mL) over time (hours) for three different strengths of Estradiol topical gel: 0.25 mg, 0.5 mg, and 1.0 mg. The x-axis represents time from 0 to 24 hours, and the y-axis shows estradiol concentration ranging up to 100 pg/mL. Data points for each strength are plotted with error bars indicating variability.*

FDA Label Image

Estradiol-structure (Structure)

Chemical structure of estradiol, showing the steroid ring system with hydroxyl functional groups attached at specific positions.*

FDA Label Image

Table-5 (Table Five)

A data table titled 'Relative And Absolute Risk Seen in the Estrogen Plus Progestin Substudy of WHI at an Average of 5.6 Years' showing various health events, relative risks comparing CE/MPA versus placebo, and absolute risk per 10,000 woman-years for CE/MPA and placebo groups. Events listed include CHD events, strokes, deep vein thrombosis, pulmonary embolism, cancers, fractures, overall mortality, and a global index. Footnotes note data sources and definitions relevant to the study results.*

FDA Label Image

Table-4 (Table Four)

A data table titled 'Relative And Absolute Risk Seen In The Estrogen-Alone Substudy Of WHI' comparing relative risk and absolute risk per 10,000 woman-years for various health events between conjugated estrogen (CE) and placebo groups. The table lists events such as coronary heart disease, stroke types, thrombosis, cancers, fractures, total fractures, death causes, and overall mortality, with corresponding risk estimates, confidence intervals, and incidence counts for CE and placebo cohorts.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.